Novel Claromer compounds fight viruses by targeting their protective membranes
Maxwell Biosciences - 02-Aug-2023Inspired by human immunity, Claromers are revolutionary molecules which may overcome resistance in near future
Join the club for FREE to access the whole archive and other member benefits.
Professor of chemistry at NYU and Chief Scientific Officer at Maxwell Biosciences
Kent Kirshenbaum is currently a professor of chemistry at New York University and Chief Scientific Officer at Maxwell Biosciences. His research interests are Bioorganic Chemistry, Biomimetic Chemistry, Protein Conformation and Dynamics, and Macromolecular Design.
Kent completed B.A. in Chemistry at Reed College, Ph.D. in Pharmaceutical Chemistry at University of California, San Francisco, followed by postdoctoral fellowship at California Institute of Technology.
Visit website: https://as.nyu.edu/faculty/kent-kirshenbaum.html
See also: New York University (NYU) - One of the world’s foremost research universities
Details last updated 25-Aug-2023
Inspired by human immunity, Claromers are revolutionary molecules which may overcome resistance in near future